Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $CORT vs $ELAN | Chartloom

Compare

$CORT vs $ELAN

Corcept Therapeutics Inc · Elanco Animal Health Inc

CORT

Corcept Therapeutics Inc

ELAN

Elanco Animal Health Inc

Compare $CORT vs $ELAN

Comparing Corcept Therapeutics Inc and Elanco Animal Health Inc

CORTCorcept Therapeutics Inc

ELANElanco Animal Health Inc

CORTCorcept Therapeutics Inc

Market cap

$12.73B

P/E (TTM)

252.72x

Forward P/E (NTM)

28.94x

Forward P/S (NTM)

8.27x

Rev growth (TTM)

16.0%

YTD performance

208.4%

52W performance

59.3%

FCF yield

0.8%

ELANElanco Animal Health Inc

Market cap

$11.19B

P/E (TTM)

—

Forward P/E (NTM)

18.48x

Forward P/S (NTM)

2.09x

Rev growth (TTM)

12.0%

YTD performance

-0.5%

52W performance

13.4%

FCF yield

3.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CORT

ELAN

Detailed metrics comparison

CORT

Corcept Therapeutics Inc

ELAN

Elanco Animal Health Inc

Market Cap

CORT$12.73B

ELAN$11.19B

Enterprise Value

CORT$12.62B

ELAN$14.58B

Price

CORT$117.80

ELAN$22.41

P/E Ratio

CORT252.72x

ELANN/A

P/S Ratio

CORT15.33x

ELAN2.23x

EV/Sales

CORT15.19x

ELAN2.90x

EV/EBITDA

CORT1,442.80x

ELAN14.20x

P/B Ratio

CORT18.56x

ELAN1.74x

P/FCF Ratio

CORT119.10x

ELAN29.53x

EV/FCF

CORT118.06x

ELAN38.47x

PEG Ratio

CORTN/A

ELANN/A

Forward P/E (NTM)

CORT28.94x

ELAN18.48x

Forward P/S (NTM)

CORT8.27x

ELAN2.09x

Revenue (TTM)

CORT$831M

ELAN$5.02B

Revenue Growth (YoY)

CORT16.0%

ELAN12.0%

Forward Rev Growth

CORT48.8%

ELAN5.4%

Gross Margin (TTM)

CORT98.3%

ELAN55.4%

Operating Margin (TTM)

CORT0.8%

ELAN0.0%

EBITDA Margin (TTM)

CORT1.0%

ELAN20.4%

Net Margin (TTM)

CORT6.6%

ELAN-4.0%

FCF Margin (TTM)

CORT12.9%

ELAN7.5%

Net Income (TTM)

CORT$55M

ELAN$-199M

FCF (TTM)

CORT$107M

ELAN$379M

EPS (TTM)

CORT$0.47

ELAN-$0.39

ROE (TTM)

CORT8.4%

ELAN-302.0%

ROA (TTM)

CORT6.6%

ELAN-148.0%

ROIC (TTM)

CORT8.4%

ELAN-188.0%

Cash

CORT$111M

ELAN$530M

Debt

CORT$0

ELAN$3.92B

Net Cash/Debt

CORT$111M

ELAN$-3.39B

Current Ratio (TTM)

CORT2.86x

ELAN2.05x

Quick Ratio (TTM)

CORT2.63x

ELAN0.91x

Debt/Equity (TTM)

CORT0.00x

ELAN0.59x

Debt/Assets (TTM)

CORT0.0%

ELAN0.0%

Interest Coverage (TTM)

CORTN/A

ELANN/A

Net Debt/EBITDA (TTM)

CORT0.00x

ELAN0.00x

Beta

CORT0.52

ELAN1.75

52W Performance

CORT59.3%

ELAN13.4%

YTD Performance

CORT208.4%

ELAN-0.5%

% from 52W High

CORT-6.8%

ELAN-19.9%

% from 52W Low

CORT311.0%

ELAN15.5%

Asset Turnover (TTM)

CORT0.99x

ELAN0.37x

FCF Yield (TTM)

CORT0.8%

ELAN3.4%

Earnings Yield (TTM)

CORT0.4%

ELAN-1.8%

Dividend Yield (TTM)

CORTN/A

ELANN/A

Rule of 40

CORT28.9

ELAN19.5

EV/GP/RG

CORT0.18

ELAN0.76

Ticker research

View CORT research View ELAN research

Metric	CORT Corcept Therapeutics Inc	ELAN Elanco Animal Health Inc
Market & Valuation
Market Cap	$12.73B	$11.19B
Enterprise Value	$12.62B	$14.58B
Price	$117.80	$22.41
P/E Ratio	252.72x	N/A
P/S Ratio	15.33x	2.23x
EV/Sales	15.19x	2.90x
EV/EBITDA	1,442.80x	14.20x
P/B Ratio	18.56x	1.74x
P/FCF Ratio	119.10x	29.53x
EV/FCF	118.06x	38.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	28.94x	18.48x
Forward P/S (NTM)	8.27x	2.09x
Revenue & Growth
Revenue (TTM)	$831M	$5.02B
Revenue Growth (YoY)	16.0%	12.0%
Forward Rev Growth	48.8%	5.4%
Profitability
Gross Margin (TTM)	98.3%	55.4%
Operating Margin (TTM)	0.8%	0.0%
EBITDA Margin (TTM)	1.0%	20.4%
Net Margin (TTM)	6.6%	-4.0%
FCF Margin (TTM)	12.9%	7.5%
Net Income (TTM)	$55M	$-199M
FCF (TTM)	$107M	$379M
EPS (TTM)	$0.47	-$0.39
ROE (TTM)	8.4%	-302.0%
ROA (TTM)	6.6%	-148.0%
ROIC (TTM)	8.4%	-188.0%
Financial Health
Cash	$111M	$530M
Debt	$0	$3.92B
Net Cash/Debt	$111M	$-3.39B
Current Ratio (TTM)	2.86x	2.05x
Quick Ratio (TTM)	2.63x	0.91x
Debt/Equity (TTM)	0.00x	0.59x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	1.75
52W Performance	59.3%	13.4%
YTD Performance	208.4%	-0.5%
% from 52W High	-6.8%	-19.9%
% from 52W Low	311.0%	15.5%
Efficiency & Yields
Asset Turnover (TTM)	0.99x	0.37x
FCF Yield (TTM)	0.8%	3.4%
Earnings Yield (TTM)	0.4%	-1.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	28.9	19.5
EV/GP/RG	0.18	0.76
Ticker research	View CORT research	View ELAN research

Valuation

P/E Ratio

CORT

252.72x

P/S Ratio

ELAN

2.23x

CORT

15.33x

EV/FCF

ELAN

38.47x

CORT

118.06x

Growth & revenue

Revenue Growth TTM

CORT

16.0%

ELAN

12.0%

Forward Revenue Growth

CORT

48.8%

ELAN

5.4%

Profitability & performance

Gross Margin

CORT

98.3%

ELAN

55.4%

ROE

CORT

8.4%

ELAN

-302.0%

FCF Yield %

ELAN

3.4%

CORT

0.8%

52-Week Performance

CORT

59.3%

ELAN

13.4%

Detailed metrics comparison

CORT

Corcept Therapeutics Inc

ELAN

Elanco Animal Health Inc

Market Cap

CORT$12.73B

ELAN$11.19B

Enterprise Value

CORT$12.62B

ELAN$14.58B

Price

CORT$117.80

ELAN$22.41

P/E Ratio

CORT252.72x

ELANN/A

P/S Ratio

CORT15.33x

ELAN2.23x

EV/Sales

CORT15.19x

ELAN2.90x

EV/EBITDA

CORT1,442.80x

ELAN14.20x

P/B Ratio

CORT18.56x

ELAN1.74x

P/FCF Ratio

CORT119.10x

ELAN29.53x

EV/FCF

CORT118.06x

ELAN38.47x

PEG Ratio

CORTN/A

ELANN/A

Forward P/E (NTM)

CORT28.94x

ELAN18.48x

Forward P/S (NTM)

CORT8.27x

ELAN2.09x

Revenue (TTM)

CORT$831M

ELAN$5.02B

Revenue Growth (YoY)

CORT16.0%

ELAN12.0%

Forward Rev Growth

CORT48.8%

ELAN5.4%

Gross Margin (TTM)

CORT98.3%

ELAN55.4%

Operating Margin (TTM)

CORT0.8%

ELAN0.0%

EBITDA Margin (TTM)

CORT1.0%

ELAN20.4%

Net Margin (TTM)

CORT6.6%

ELAN-4.0%

FCF Margin (TTM)

CORT12.9%

ELAN7.5%

Net Income (TTM)

CORT$55M

ELAN$-199M

FCF (TTM)

CORT$107M

ELAN$379M

EPS (TTM)

CORT$0.47

ELAN-$0.39

ROE (TTM)

CORT8.4%

ELAN-302.0%

ROA (TTM)

CORT6.6%

ELAN-148.0%

ROIC (TTM)

CORT8.4%

ELAN-188.0%

Cash

CORT$111M

ELAN$530M

Debt

CORT$0

ELAN$3.92B

Net Cash/Debt

CORT$111M

ELAN$-3.39B

Current Ratio (TTM)

CORT2.86x

ELAN2.05x

Quick Ratio (TTM)

CORT2.63x

ELAN0.91x

Debt/Equity (TTM)

CORT0.00x

ELAN0.59x

Debt/Assets (TTM)

CORT0.0%

ELAN0.0%

Interest Coverage (TTM)

CORTN/A

ELANN/A

Net Debt/EBITDA (TTM)

CORT0.00x

ELAN0.00x

Beta

CORT0.52

ELAN1.75

52W Performance

CORT59.3%

ELAN13.4%

YTD Performance

CORT208.4%

ELAN-0.5%

% from 52W High

CORT-6.8%

ELAN-19.9%

% from 52W Low

CORT311.0%

ELAN15.5%

Asset Turnover (TTM)

CORT0.99x

ELAN0.37x

FCF Yield (TTM)

CORT0.8%

ELAN3.4%

Earnings Yield (TTM)

CORT0.4%

ELAN-1.8%

Dividend Yield (TTM)

CORTN/A

ELANN/A

Rule of 40

CORT28.9

ELAN19.5

EV/GP/RG

CORT0.18

ELAN0.76

Ticker research

View CORT research View ELAN research

Metric	CORT Corcept Therapeutics Inc	ELAN Elanco Animal Health Inc
Market & Valuation
Market Cap	$12.73B	$11.19B
Enterprise Value	$12.62B	$14.58B
Price	$117.80	$22.41
P/E Ratio	252.72x	N/A
P/S Ratio	15.33x	2.23x
EV/Sales	15.19x	2.90x
EV/EBITDA	1,442.80x	14.20x
P/B Ratio	18.56x	1.74x
P/FCF Ratio	119.10x	29.53x
EV/FCF	118.06x	38.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	28.94x	18.48x
Forward P/S (NTM)	8.27x	2.09x
Revenue & Growth
Revenue (TTM)	$831M	$5.02B
Revenue Growth (YoY)	16.0%	12.0%
Forward Rev Growth	48.8%	5.4%
Profitability
Gross Margin (TTM)	98.3%	55.4%
Operating Margin (TTM)	0.8%	0.0%
EBITDA Margin (TTM)	1.0%	20.4%
Net Margin (TTM)	6.6%	-4.0%
FCF Margin (TTM)	12.9%	7.5%
Net Income (TTM)	$55M	$-199M
FCF (TTM)	$107M	$379M
EPS (TTM)	$0.47	-$0.39
ROE (TTM)	8.4%	-302.0%
ROA (TTM)	6.6%	-148.0%
ROIC (TTM)	8.4%	-188.0%
Financial Health
Cash	$111M	$530M
Debt	$0	$3.92B
Net Cash/Debt	$111M	$-3.39B
Current Ratio (TTM)	2.86x	2.05x
Quick Ratio (TTM)	2.63x	0.91x
Debt/Equity (TTM)	0.00x	0.59x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	1.75
52W Performance	59.3%	13.4%
YTD Performance	208.4%	-0.5%
% from 52W High	-6.8%	-19.9%
% from 52W Low	311.0%	15.5%
Efficiency & Yields
Asset Turnover (TTM)	0.99x	0.37x
FCF Yield (TTM)	0.8%	3.4%
Earnings Yield (TTM)	0.4%	-1.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	28.9	19.5
EV/GP/RG	0.18	0.76
Ticker research	View CORT research	View ELAN research